BNP Paribas Financial Markets
EDIT icon

BNP Paribas Financial Markets’s Editas Medicine EDIT Stock Holding History

BNP Paribas Financial Markets’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.2K Sell
21,985
-914
-4% -$2.67K ﹤0.01% 4716
2026
Q1 		$56.6K Sell
22,899
-10,096
-31% -$21.4K ﹤0.01% 4630
2025
Q4 		$67.6K Buy
32,995
+5,827
+21% +$16.8K ﹤0.01% 4550
2025
Q3 		$94.3K Buy
27,168
+6,787
+33% +$18.9K ﹤0.01% 4330
2025
Q2 		$44.8K Sell
20,381
-25,257
-55% -$41.3K ﹤0.01% 4296
2025
Q1 		$52.9K Sell
45,638
-98,422
-68% -$145K ﹤0.01% 4271
2024
Q4 		$183K Buy
144,060
+89,273
+163% +$227K ﹤0.01% 3915
2024
Q3 		$187K Buy
54,787
+14,888
+37% +$64.8K ﹤0.01% 3273
2024
Q2 		$186K Sell
39,899
-42,911
-52% -$242K ﹤0.01% 3122
2024
Q1 		$614K Sell
82,810
-132,201
-61% -$1.1M ﹤0.01% 2733
2023
Q4 		$2.18M Sell
215,011
-334,059
-61% -$2.93M ﹤0.01% 1905
2023
Q3 		$4.28M Buy
549,070
+209,708
+62% +$1.8M 0.01% 1376
2023
Q2 		$2.79M Sell
339,362
-102,269
-23% -$891K ﹤0.01% 1563
2023
Q1 		$3.2M Buy
441,631
+177,387
+67% +$1.58M ﹤0.01% 1524
2022
Q4 		$2.34M Buy
264,244
+74,959
+40% +$823K ﹤0.01% 1678
2022
Q3 		$2.32M Buy
189,285
+99,273
+110% +$1.55M ﹤0.01% 1870
2022
Q2 		$1.06M Sell
90,012
-60,294
-40% -$808K ﹤0.01% 2160
2022
Q1 		$2.86M Buy
150,306
+23,967
+19% +$446K ﹤0.01% 1605
2021
Q4 		$3.35M Buy
126,339
+19,689
+18% +$678K ﹤0.01% 1635
2021
Q3 		$4.38M Buy
106,650
+79,478
+292% +$4.35M 0.01% 1378
2021
Q2 		$1.54M Sell
27,172
-17,040
-39% -$629K ﹤0.01% 1912
2021
Q1 		$1.86M Buy
44,212
+13,093
+42% +$746K ﹤0.01% 1726
2020
Q4 		$2.18M Buy
31,119
+10,495
+51% +$431K ﹤0.01% 1588
2020
Q3 		$579K Buy
20,624
+3,927
+24% +$128K ﹤0.01% 2129
2020
Q2 		$494K Sell
16,697
-26,333
-61% -$688K ﹤0.01% 2109
2020
Q1 		$853K Sell
43,030
-132,090
-75% -$3.33M ﹤0.01% 2024
2019
Q4 		$5.19M Buy
175,120
+166,582
+1,951% +$4.16M 0.01% 1170
2019
Q3 		$194K Buy
8,538
+2,346
+38% +$58.1K ﹤0.01% 2765
2019
Q2 		$153K Sell
6,192
-4,395
-42% -$105K ﹤0.01% 2782
2019
Q1 		$259K Buy
10,587
+9,606
+979% +$217K ﹤0.01% 2539
2018
Q4 		$22.3K Sell
981
-1,509
-61% -$41.1K ﹤0.01% 3072
2018
Q3 		$79.2K Buy
2,490
+207
+9% +$6.69K ﹤0.01% 2866
2018
Q2 		$81.8K Sell
2,283
-5,427
-70% -$192K ﹤0.01% 2889
2018
Q1 		$256K Buy
7,710
+428
+6% +$15.3K ﹤0.01% 2655
2017
Q4 		$224K Buy
7,282
+3,470
+91% +$87.4K ﹤0.01% 2910
2017
Q3 		$91.5K Sell
3,812
-137
-3% -$2.61K ﹤0.01% 2830
2017
Q2 		$66.3K Buy
3,949
+3,508
+795% +$63.2K ﹤0.01% 3042
2017
Q1 		$9.84K Sell
441
-193
-30% -$4K ﹤0.01% 3181
2016
Q4 		$10.3K Sell
634
-100
-14% -$1.52K ﹤0.01% 3445
2016
Q3 		$9.89K Buy
734
+461
+169% +$9.45K ﹤0.01% 3171
2016
Q2 		$6.66K Buy
+273
New +$9.21K ﹤0.01% 3120

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

BNP Paribas Financial Markets's EDIT Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Editas Medicine (EDIT) stake by 4% in Q2 2026, selling an estimated $2.67K and leaving 21,985 shares worth $71.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4716.

BNP Paribas Financial Markets first reported a position in EDIT in Q2 2016 and has held it in 41 quarters since. The position peaked at $5.19M in Q4 2019. 199 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • BNP Paribas Financial Markets held 21,985 shares of Editas Medicine worth $71.2K as of Q2 2026.
  • BNP Paribas Financial Markets sold 914 Editas Medicine shares in Q2 2026, an estimated $2.67K.
  • Editas Medicine made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4716 holding.
  • BNP Paribas Financial Markets first reported a position in Editas Medicine in Q2 2016 and has held it in 41 quarters since.
  • BNP Paribas Financial Markets's Editas Medicine position peaked at $5.19M in Q4 2019.
  • 199 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.